| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |